LISATA THERAPEUTICS, INC. (LSTA) Earnings Signals & AI Vibe Check
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for LISATA THERAPEUTICS, INC.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, LISATA THERAPEUTICS, INC.'s filing signal
turned positive.
earningsVibe SuperAnalyst™ Verdict:
TURNED POSITIVE
Signal Performance — Stock Price Since Filing
30-Day Change
-0.40%
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Turned Positive
GEMINI
Turned Negative
CLAUDE
Turned Positive
CHATGPT
Turned Negative
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does LISATA THERAPEUTICS, INC. actually do?
Answer:
Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing and commercializing therapies for solid tumors and other serious diseases. Its lead investigational product, certepetide, is designed to enhance the delivery and efficacy of co-administered anti-cancer drugs by activating a tumor-specific uptake pathway. Certepetide also aims to modify the tumor microenvironment to improve immunotherapy response and inhibit metastasis. The company has conducted multiple Phase 2 clinical studies globally for various solid tumors, including pancreatic cancer, and is currently exploring strategic partnerships. Lisata Therapeutics is subject to a proposed acquisition by Kuva Labs, Inc., expected to close in the second quarter of 2026.
Question:
What are LISATA THERAPEUTICS, INC.'s revenue drivers?
Answer:
Revenue is primarily driven by upfront license fees and collaboration agreements. The company does not currently generate revenue from product sales.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required